Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.

T-lymphocytes antigen-presenting cells intraductal carcinoma of the prostate prostate cancer radical prostatectomy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
09 Apr 2023
Historique:
received: 23 02 2023
revised: 03 04 2023
accepted: 07 04 2023
medline: 16 5 2023
pubmed: 16 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Intraductal carcinoma of the prostate (IDC-P) is an aggressive histological subtype of prostate cancer (PCa) detected in approximately 20% of radical prostatectomy (RP) specimens. As IDC-P has been associated with PCa-related death and poor responses to standard treatment, the purpose of this study was to explore the immune infiltrate of IDC-P. Hematoxylin- and eosin-stained slides from 96 patients with locally advanced PCa who underwent RP were reviewed to identify IDC-P. Immunohistochemical staining of CD3, CD8, CD45RO, FoxP3, CD68, CD163, CD209 and CD83 was performed. For each slide, the number of positive cells per mm

Identifiants

pubmed: 37190147
pii: cancers15082217
doi: 10.3390/cancers15082217
pmc: PMC10137226
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : CIHR
ID : CRP-154487
Pays : Canada

Références

Prostate. 2014 Oct;74(14):1452-61
pubmed: 25111810
Nat Rev Immunol. 2021 Aug;21(8):485-498
pubmed: 33526920
Eur Urol. 2021 Jun;79(6):707-709
pubmed: 32847702
Br J Urol. 1998 Mar;81(3):413-8
pubmed: 9523662
J Urol. 2019 Apr;201(4):759-768
pubmed: 30652989
Front Genet. 2021 Nov 02;12:774846
pubmed: 34795698
Urology. 1999 Sep;54(3):467-72
pubmed: 10475356
Clin Cancer Res. 2020 Apr 15;26(8):2047-2064
pubmed: 31796516
J Clin Oncol. 2008 Mar 1;26(7):1148-59
pubmed: 18309951
Br J Cancer. 2004 Aug 2;91(3):541-3
pubmed: 15266325
Eur J Cancer. 2014 Jun;50(9):1610-6
pubmed: 24703897
Cell. 2015 May 21;161(5):1215-1228
pubmed: 26000489
JAMA Oncol. 2019 Apr 01;5(4):471-478
pubmed: 30589920
Prostate. 2018 Jan;78(1):11-16
pubmed: 29094384
Mod Pathol. 2013 Mar;26(3):448-55
pubmed: 23041830
J Exp Clin Cancer Res. 2019 Jun 19;38(1):268
pubmed: 31217020
Oncogene. 2014 May 8;33(19):2423-31
pubmed: 23728338
Eur J Cancer. 1994;30A(12):1797-803
pubmed: 7880609
Am J Surg Pathol. 1996 Jul;20(7):802-14
pubmed: 8669528
Nat Med. 2022 Apr;28(4):724-734
pubmed: 35314843
Urol Oncol. 2017 Dec;35(12):673.e9-673.e14
pubmed: 28919182
Hum Pathol. 1998 Oct;29(10):1119-23
pubmed: 9781651
J Urol. 2019 Oct;202(4):710-716
pubmed: 31059665
J Clin Oncol. 2020 Feb 10;38(5):395-405
pubmed: 31774688
Eur Urol. 2017 Oct;72(4):492-495
pubmed: 28342640
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Oncotarget. 2017 Jul 24;8(33):55374-55383
pubmed: 28903426
Mod Pathol. 2016 Feb;29(2):166-73
pubmed: 26743470
Histopathology. 2008 Jul;53(1):30-8
pubmed: 18510570
Mod Pathol. 2006 Dec;19(12):1528-35
pubmed: 16980940
Nat Med. 2014 Jun;20(6):607-15
pubmed: 24793239
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2333-44
pubmed: 24083995
Prostate. 2017 Jun;77(8):859-865
pubmed: 28240424
Prostate. 2014 May;74(6):680-7
pubmed: 24481730
J Natl Cancer Inst. 2018 Feb 1;110(2):
pubmed: 28859291
Endocr Relat Cancer. 2021 Jul 15;28(8):T95-T107
pubmed: 34128831
Mod Pathol. 2018 Oct;31(10):1539-1552
pubmed: 29849114
Cancers (Basel). 2022 Feb 06;14(3):
pubmed: 35159086
J Pathol. 2016 Jan;238(1):31-41
pubmed: 26331372
Mod Pathol. 2015 Jun;28(6):766-77
pubmed: 25720324
Eur Urol. 2017 Nov;72(5):665-674
pubmed: 28511883
J Clin Oncol. 2019 May 1;37(13):1051-1061
pubmed: 30817251
Cell Mol Immunol. 2020 Aug;17(8):807-821
pubmed: 32612154
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26
pubmed: 24966964
Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493
pubmed: 32589068
BJU Int. 2018 Dec;122(6):994-1002
pubmed: 29772102
Eur J Cancer. 2013 Apr;49(6):1273-9
pubmed: 23266046
APMIS. 2012 Nov;120(11):901-8
pubmed: 23009114
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
Anesth Analg. 2018 May;126(5):1763-1768
pubmed: 29481436
PLoS Med. 2012;9(5):e1001216
pubmed: 22675273
Clin Cancer Res. 2021 Sep 1;27(17):4836-4847
pubmed: 34168052
Eur Urol. 2016 Jul;70(1):106-119
pubmed: 26996659
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
Anticancer Res. 2005 Nov-Dec;25(6C):4435-8
pubmed: 16334122
Adv Anat Pathol. 2021 Jul 1;28(4):276-287
pubmed: 33990497
Prostate. 2015 Feb 15;75(3):225-32
pubmed: 25307858

Auteurs

Mame-Kany Diop (MK)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (axe Cancer) and Institut du Cancer de Montréal, 900 Saint-Denis, Montréal, QC H2X 0A9, Canada.
Department of Pathology and Cellular Biology, Université de Montréal, 2900 Boulevard Édouard-Montpetit, Montréal, QC H3T 1J4, Canada.

Oscar Eduardo Molina (OE)

Centre de Recherche du CHU de Québec-Université Laval (axe Oncologie), Hôpital L'Hôtel-Dieu de Québec, 9 McMahon, Québec, QC G1R 3S3, Canada.

Mirela Birlea (M)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (axe Cancer) and Institut du Cancer de Montréal, 900 Saint-Denis, Montréal, QC H2X 0A9, Canada.

Hélène LaRue (H)

Centre de Recherche du CHU de Québec-Université Laval (axe Oncologie), Hôpital L'Hôtel-Dieu de Québec, 9 McMahon, Québec, QC G1R 3S3, Canada.

Hélène Hovington (H)

Centre de Recherche du CHU de Québec-Université Laval (axe Oncologie), Hôpital L'Hôtel-Dieu de Québec, 9 McMahon, Québec, QC G1R 3S3, Canada.

Bernard Têtu (B)

Centre de Recherche du CHU de Québec-Université Laval (axe Oncologie), Hôpital L'Hôtel-Dieu de Québec, 9 McMahon, Québec, QC G1R 3S3, Canada.
Department of Pathology, CHU de Québec-Université Laval, 11 Côte du Palais, Québec, QC G1R 2J6, Canada.

Louis Lacombe (L)

Centre de Recherche du CHU de Québec-Université Laval (axe Oncologie), Hôpital L'Hôtel-Dieu de Québec, 9 McMahon, Québec, QC G1R 3S3, Canada.
Department of Surgery, Université Laval, 2325 rue de l'Université, Québec, QC G1V 0A6, Canada.

Alain Bergeron (A)

Centre de Recherche du CHU de Québec-Université Laval (axe Oncologie), Hôpital L'Hôtel-Dieu de Québec, 9 McMahon, Québec, QC G1R 3S3, Canada.
Department of Surgery, Université Laval, 2325 rue de l'Université, Québec, QC G1V 0A6, Canada.

Yves Fradet (Y)

Centre de Recherche du CHU de Québec-Université Laval (axe Oncologie), Hôpital L'Hôtel-Dieu de Québec, 9 McMahon, Québec, QC G1R 3S3, Canada.
Department of Surgery, Université Laval, 2325 rue de l'Université, Québec, QC G1V 0A6, Canada.

Dominique Trudel (D)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (axe Cancer) and Institut du Cancer de Montréal, 900 Saint-Denis, Montréal, QC H2X 0A9, Canada.
Department of Pathology and Cellular Biology, Université de Montréal, 2900 Boulevard Édouard-Montpetit, Montréal, QC H3T 1J4, Canada.
Department of Pathology, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, QC H2X 0C1, Canada.

Classifications MeSH